Canton Strategic Holdings, Inc. is a publicly traded company pioneering the use of Canton Coin (CC) and the Canton Network to promote institutional blockchain adoption and digitize financial markets. Initially focused on biotechnology through 2025, the company shifted in late 2025 to prioritize digital asset treasury management centered on CC and the Canton Network. The company operates as a Super Validator on the network, earning protocol-based rewards and supporting network security and governance. It also plans to invest in applications and middleware that enhance capital markets transactions on the network and collaborates with ecosystem participants to advance adoption. The company holds its CC tokens with institutional custodians under regulatory oversight and maintains strong liquidity. The Canton Network is a permissionless blockchain designed for institutional privacy and interoperability, processing trillions in tokenized assets. The company sold its biotech subsidiary Gravitas in mid-2026, focusing fully on its digital asset strategy.
Genprex, Inc. is a clinical-stage biotechnology company developing gene therapies targeting oncology and diabetes. The company holds exclusive worldwide licenses for gene therapy technologies from the University of Pittsburgh, focusing on gene therapies using Pdx1 and MafA transcription factors for Type 1 and Type 2 diabetes. Genprex formed a wholly-owned subsidiary, Convergen Biotech, Inc., to potentially separate its diabetes clinical development program from oncology assets. The company has sustained losses since inception and currently has no revenue. It reported net losses of approximately $4.45 million for the quarter ended June 30, 2026, and held cash and cash equivalents of about $15.15 million at that date. Genprex has implemented multiple reverse stock splits to maintain Nasdaq listing compliance and currently holds an exception from the Nasdaq Hearings Panel to demonstrate compliance with minimum bid price requirements through December 7, 2026. The company’s intellectual property portfolio includes 15 granted patents and 28 pending applications worldwide. Research collaborations have produced preclinical data supporting therapeutic potential in non-human primate models of Type 1 diabetes.
Paranovus Entertainment Technology Ltd. is a foreign private issuer listed on Nasdaq, operating in the social commerce and entertainment technology space. The company has a board of five directors with detailed executive management disclosed. As of March 31, 2026, Paranovus employed 34 full-time staff across the U.S. and China. The company reported revenues of approximately $14.6 million and a net loss of $12.7 million for the fiscal year ended March 31, 2026. Paranovus maintains strong liquidity with a current ratio above 8 and a cash ratio above 6 as of the same date. Recent strategic activity includes regaining Nasdaq listing compliance and acquiring assets related to the Heyviva athletic wear brand from Jabanero Inc. for $33 million in cash, aiming to leverage synergies with its social commerce capabilities.
Wintergreen Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in April 2024. Its business model is to identify and complete a business combination with one or more target companies, primarily focusing on private companies in Asia, excluding those with China operations via VIE structures. The company completed its IPO in May 2025, raising gross proceeds of approximately $58 million, which are held in a trust account invested in U.S. government securities or money market funds. Wintergreen has not commenced operations and does not generate operating revenues until after consummating a business combination. The company entered into a merger agreement with KIKA Technology Inc., a Cayman Islands holding company with operating subsidiaries in Hong Kong providing AdTech Dynamic Matching Technology services. The business combination values KIKA at $80 million, with KIKA shareholders to receive shares of Wintergreen upon closing. Wintergreen plans to change its name to KIKA Inc. following the transaction. The company’s management team has experience in financial services, accounting, legal, and senior operating roles, with expertise in mergers and acquisitions and operating companies.
BHAV Acquisition Corp is a publicly reporting entity with recent financial disclosures through SEC filings. The company holds significant short-term investments and maintains a strong liquidity position as of the latest quarter. Specific details about its business model, sector, and industry classification are not publicly disclosed in the available filings.
Greenland Technologies Holding Corp. is a manufacturing company with subsidiaries primarily producing transmission systems and integrated powertrains for material handling machinery. The company has been diversifying into electric industrial heavy equipment. Its business model involves serving large manufacturing customers, with a significant portion of revenue concentrated among a few key clients. The company operates in a competitive environment with challenges including short delivery lead-times, long payment terms, and reliance on a limited supplier network. It faces regulatory and geopolitical risks associated with its operations in China and the U.S.-China trade environment.
PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company pioneering small molecule therapies that target mutant p53 proteins, which are implicated in about half of all cancers. Founded in 2013, PMV focuses on restoring the tumor suppressor function of mutant p53 through its lead candidate, rezatapopt. The company initiated the PYNNACLE Phase 1/2 clinical trial in 2020, with the Phase 2 portion designed as a pivotal study. Rezatapopt has received FDA Fast Track and Orphan Drug Designations. PMV plans to submit an NDA for platinum-resistant/refractory ovarian cancer in early 2027. The company has no commercial products and has incurred net losses since inception, funding operations primarily through equity and other financings. As of mid-2026, PMV maintains strong liquidity but management has expressed substantial doubt about its ability to continue as a going concern beyond one year from the latest filing date.
Lightwave Logic, Inc. develops proprietary electro-optic polymer materials designed for integration into silicon photonics and photonic integrated circuits to enable high-speed, high-bandwidth optical modulators with lower drive voltages and compact footprints. The company’s Perkinamine® materials are compatible with CMOS fabrication processes, facilitating integration into established semiconductor foundry workflows. Lightwave Logic’s business model centers on material sales, intellectual property licensing, and royalty or fee-based arrangements tied to customer production. Customers include semiconductor foundries, device designers, and system integrators serving AI, cloud computing, data center, and telecommunications markets. The company pursues customer adoption through a structured Design Win Cycle spanning 18 to 24 months, progressing from technology evaluation to potential production ramp. As of early 2026, multiple customer programs are in various development stages, with revenues primarily from material supply, non-recurring engineering fees, and prototype activities. The company does not manufacture finished optical devices but enables customers to incorporate its materials into their platforms.
Coherent Corp. develops, manufactures, and markets lasers, transceivers, optical and optoelectronic devices, modules, systems, and engineered materials. Its products serve datacenter and communications markets, including AI datacenter infrastructure, and industrial markets such as semiconductor capital equipment, precision manufacturing, life sciences, and scientific research. The company operates globally with manufacturing and R&D facilities in the United States, China, Germany, Malaysia, Vietnam, and other countries. It sells products through direct sales and distributors. Coherent's business is organized into two reportable segments: Datacenter & Communications and Industrial. The company has strategic agreements with major technology firms, notably NVIDIA, which includes a significant equity investment and purchase commitments. Coherent has undertaken restructuring plans to optimize its cost structure and manufacturing footprint. The company faces risks related to tariffs, export controls, and geopolitical factors but has mitigations through its diversified supply chain and manufacturing capabilities.
HawkEye 360, Inc. is a commercial provider of space-based signals intelligence and RF spectrum exploitation services. Founded in 2015, the company offers a proprietary platform that detects and locates RF emitters, serving primarily government and allied international customers. Its business model relies heavily on government contracts, including indefinite delivery/indefinite quantity (IDIQ) contracts that do not guarantee revenue. The company has grown rapidly but operates in a novel and evolving market with inherent uncertainties. HawkEye 360 invests in satellite launches, technology development, and acquisitions to expand its capabilities and customer base.
NexPoint Diversified Real Estate Trust operates as a real estate investment trust (REIT) that invests in diversified real estate assets, including interests in entities that are also REITs. The company elected to be treated as a REIT starting with the taxable year ended December 31, 2021, which subjects it to complex qualification requirements under U.S. federal income tax law. The company’s Adviser and Sponsor manage multiple affiliated investment funds with potentially competing investment objectives, creating conflicts of interest. The Board has authority to issue preferred shares and implement provisions that may delay or prevent changes in control. The company reported $11.666 million in cash and cash equivalents and $19.337 million in revenue for the quarter ended June 30, 2026, with net income of $61,000. Recent news coverage includes dividend declarations, insider buying, and preferred share yield information.
GRI Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for diseases caused by dysregulated immune responses, including inflammatory, fibrotic, and autoimmune disorders. The company's lead product candidate, GRI-0621, is an oral inhibitor of type 1 invariant natural killer T (iNKT) cells, formulated as an oral form of tazarotene, which is approved topically for psoriasis and acne but not previously as an oral formulation. GRI-0621 is being developed primarily for idiopathic pulmonary fibrosis (IPF), a severe and progressive lung disease with limited treatment options. The company has conducted a Phase 2a clinical trial demonstrating safety and tolerability of GRI-0621, with biomarker and functional data suggesting anti-fibrotic effects. GRI Bio also has a pipeline including GRI-0803, targeting autoimmune diseases such as lupus and multiple sclerosis. The company has raised capital through public offerings and maintains strong liquidity as of mid-2026. It faces regulatory and market risks including potential Nasdaq listing compliance challenges.
QXO, Inc. operates as the largest publicly-traded distributor of roofing, waterproofing, and complementary building products in North America. The company transitioned from a technology services provider to a building products distributor following its acquisition of Beacon Roofing Supply in April 2025. QXO serves a broad customer base including contractors, builders, and retailers across the U.S. and Canada through approximately 600 branches. Its product portfolio includes asphalt shingles, single-ply membranes, insulation, siding, waterproofing, plywood/OSB, windows, and doors, with private label offerings under the TRI-BUILT® brand. The company emphasizes value-added services through a knowledgeable sales force and aims to leverage technology and AI to enhance revenue growth, margin expansion, and operational efficiency. QXO pursues a growth strategy combining organic initiatives, greenfield developments, and accretive acquisitions, targeting $50 billion in annual revenues within the next decade. The building products distribution industry is large and fragmented, with strong demand drivers including housing shortages, aging infrastructure, and repair/re-roofing needs. Seasonality and weather patterns significantly influence demand. QXO maintains strong supplier relationships and a substantial liquidity position as of mid-2026.
SEATech Ventures Corp. was incorporated in 2018 and operates through subsidiaries in Labuan, Malaysia, and Hong Kong. The company provides incubation, business mentoring, nurturing, and corporate development advisory services, focusing on the ICT sector in Asia, particularly Malaysia and Hong Kong. Its services include an ICT Start-Up Mentorship Program to assist tech entrepreneurs with technical, financial, and strategic challenges. SEATech Ventures also acts as a listing sponsor for security token offerings on Green-X, a Shariah-compliant digital asset exchange. The company targets emerging-growth entrepreneurs and SMEs in Asia, offering business and corporate advisory, capital markets and fundraising advisory, ICT sector opportunity evaluation, entrepreneur mentorship, and family office investment support. It has partnerships with the National ICT Association of Malaysia and GreenPro Capital Corp to support high-growth companies. The company had no revenue in 2025 due to economic conditions but is actively exploring new opportunities and plans to develop corporate programs such as seminars and workshops. The ICT industry in the region is growing rapidly, driven by IoT, AI, robotics, and government initiatives, providing a relevant market environment for SEATech Ventures' services. The company reported a net loss and low liquidity as of mid-2026 and is pursuing strategic acquisitions to expand its family office services.
Owlet, Inc. is a Delaware-incorporated company headquartered in Lehi, Utah, publicly traded on the NYSE under the ticker OWLT. The company has a board of directors with diverse expertise in healthcare, technology, finance, and venture capital. The CEO, Kurt Workman, is a co-founder and has held various leadership roles since the company's inception in 2012. Owlet files detailed annual and quarterly reports with the SEC, including an amended 10-K/A for 2025 and a 10-Q for Q2 2026, providing transparency into its financial condition and governance. The company reported a net loss in Q2 2026 but maintains a current ratio above 1.5, indicating liquidity. Owlet regularly communicates operational and financial updates through earnings calls and public disclosures.
BM Acquisition Corp. is a blank check company incorporated in the Cayman Islands in May 2025. Its business purpose is to complete a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, referred to as its initial business combination. The company targets acquisition candidates primarily in Southeast Asia, focusing on businesses with annual revenues between $15 million and $30 million. Southeast Asia includes eleven economies such as Malaysia, Singapore, Indonesia, Thailand, and Vietnam, which are characterized by rapid economic growth and favorable demographics. The company aims to leverage its management team's extensive financial and operational experience and regional network to access proprietary deals and execute disciplined investment strategies. The company plans to use the benefits of being a public company to offer target businesses an alternative to traditional IPOs, providing access to capital and enhanced credibility. The company has a trust account initially holding $60 million from its IPO proceeds to fund its initial business combination and future expansion. As of the latest filings, the company has not identified a specific acquisition target and reported a net loss of $4,000 for the period ending June 30, 2026.
LaFayette Acquisition Corp. is a Cayman Islands exempted special purpose acquisition company (SPAC) formed to complete a business combination with one or more target companies. The company completed its IPO in October 2025, raising approximately $118.8 million gross proceeds, which are held in a trust account pending a qualifying business combination. The management team comprises experienced professionals with backgrounds in investment banking, private equity, and SPAC governance. The company has no operating history or revenue as of the latest filings and focuses on leveraging its network and expertise to identify suitable acquisition targets.
Avnet, Inc. is a technology distribution company publicly traded on NASDAQ under the ticker AVT. The company provides a range of products and services related to electronic components and technology solutions. Its financial disclosures for fiscal year 2026 show solid profitability with net income of $334.4 million and earnings per share above $4. The company maintains a healthy liquidity position with a current ratio of 1.78 as of June 27, 2026. Recent amendments to its receivables purchase agreement increased its financing capacity and extended the facility term. The company’s business operations and risk factors are regularly disclosed in SEC filings with no material changes reported recently. News coverage emphasizes broad-based demand recovery, margin improvements, and international revenue trends, indicating active market engagement and operational execution.
Amcor plc develops and produces responsible packaging solutions globally, serving nutrition, health, beauty, and wellness sectors. Its product range includes flexible packaging, rigid packaging, cartons, and closures designed for sustainability and functionality. The company operates in over 40 countries with a workforce of approximately 77,000 employees. In 2025, Amcor completed the acquisition of Berry Global, significantly expanding its scale and product offerings. The integration of Berry is underway with targeted cost synergies and operational efficiencies. Amcor is also conducting a strategic review of its portfolio to divest or restructure less aligned businesses. The company faces macroeconomic and geopolitical challenges impacting demand, costs, and supply chains, and is implementing price and cost actions to mitigate these effects.
Standex International is a diversified industrial manufacturer headquartered in Salem, New Hampshire, delivering customized engineered solutions across diverse commercial and industrial markets. The company operates through four segments: Electronics, Aerospace & Defense, Scientific, and Engraving & Hydraulics. Standex pursues a strategy focused on portfolio simplification, organic and inorganic growth, and operational excellence under its Standex Value Creation System. Recent portfolio moves include acquisitions of companies specializing in instrument transformers, aerospace components, magnetics, and cryogenic equipment, alongside divestitures such as Federal Industries to focus on larger, fast-growth businesses. The company emphasizes customer intimacy and tailored solutions to niche markets, supported by strong cash flow used for capital investments and shareholder returns [S1][S2].
Intapp, Inc. provides AI-powered software solutions designed specifically for professional firms operating in highly regulated industries such as legal, accounting, consulting, investment banking, private capital, and real assets. The company’s core offering, Firm AI, integrates AI agents and proprietary data to automate complex firm workflows including business development, compliance, risk management, and operational efficiency. Intapp’s product suite includes Intapp Celeste, DealCloud, Intapp Properties, compliance and profitability tools, and collaboration solutions integrated with Microsoft 365. The platform is cloud-based on Microsoft Azure, emphasizing security, scalability, and seamless integration with internal and third-party systems. Intapp’s client base comprises over 1,400 enterprise clients, including a majority of top law and accounting firms, reflecting deep domain expertise and a strong market position [S1].
Alpha Cognition Inc. operates as a biopharmaceutical company dedicated to developing treatments for neurodegenerative diseases, with a focus on Alzheimer's disease. The company’s flagship product, ZUNVEYL (benzgalantamine), is a next-generation acetylcholinesterase inhibitor approved by the FDA in July 2024 and commercially launched in March 2025. ZUNVEYL targets mild to moderate Alzheimer's disease patients, particularly in the long-term care setting, and aims to improve tolerability and efficacy compared to existing treatments. The company has built a specialized commercial team and is actively pursuing formulary coverage and partnerships to support adoption. Additional preclinical programs focus on combination therapies and alternative formulations for cognitive impairment and related conditions. Alpha Cognition maintains a strong liquidity position as of mid-2026 and continues to invest in commercialization and clinical development activities.
Cyngn Inc. develops autonomous vehicle technology for industrial applications, addressing challenges such as labor shortages, high labor costs, and workplace safety. Its core product, DriveMod, is a modular, vehicle-agnostic autonomous driving software stack integrated onto industrial vehicles manufactured by OEMs. The company’s Enterprise Autonomy Suite (EAS) includes DriveMod, Cyngn Insight for fleet management and analytics, and Cyngn Evolve for AI/ML development and simulation. EAS aims to provide a universal autonomous driving solution with minimal marginal cost, enabling customers to adopt and expand autonomous fleets flexibly. Cyngn pursues a go-to-market strategy focused on collaboration with OEMs and a land-and-expand approach with end customers, targeting industries such as manufacturing, distribution, mining, construction, and agriculture. Revenue is generated through deployment projects, subscription licenses, and customization contracts. The company has commercial deployments with notable customers including John Deere, G&J Pepsi, Coats Automotive, and US Continental. Financially, Cyngn reported $144K revenue and a net loss of $6.35 million for Q2 2026, with strong liquidity supported by cash and short-term investments totaling over $39 million as of June 30, 2026.
ContextLogic Holdings Inc. is a holding company that completed a strategic reorganization in 2025, transitioning from operating an e-commerce marketplace and logistics platform to owning US Salt, a salt production and manufacturing business. The company sold its prior marketplace and logistics assets, including the Wish platform, to Qoo10 in April 2024, ceasing related revenue streams. The acquisition of US Salt in early 2026 was financed through a rights offering, backstop agreements, and term loans. The company’s financial position as of mid-2026 includes significant cash and short-term investments, with a current ratio indicating adequate liquidity. The company continues to incur administrative expenses related to overseeing its assets and integration activities. Transfer restrictions on stock ownership are in place to preserve tax attributes. The company’s prior operations and financial results are detailed in SEC filings, with recent news coverage focusing on its prior identity as LogicBio Therapeutics and related clinical developments [S1][S2][N7].
Gesher Acquisition Corp. II is a Special Purpose Acquisition Company (SPAC) incorporated in August 2024 in the Cayman Islands. It was formed to identify and complete a Business Combination with one or more target companies, focusing on Israeli businesses with international reach, excluding those principally operating in China, Hong Kong, or Macau. The company completed its IPO in March 2025, raising gross proceeds of approximately $143.75 million plus $5.66 million from private placements, with funds held in a Trust Account. The management team, led by CEO Ezra Gardner and CFO Caroline Fu, has experience in similar SPAC transactions. The company has not generated operating revenues and intends to use IPO proceeds and other financing to complete its Business Combination by December 24, 2026. The company’s financial snapshot as of June 30, 2026, shows current assets and liabilities roughly balanced, with a current ratio of 1.0 and no cash ratio due to lack of cash equivalents disclosure. The company reported net income of $944,152 for the quarter ending June 30, 2026, consistent with SPAC accounting practices.
Cineverse Corp., incorporated in 2000, is a technology and entertainment company that has evolved from pioneering digital cinema distribution to becoming a leading independent streaming and content distribution company. Its core business includes operating a portfolio of enthusiast streaming channels, aggregating and distributing feature films and TV programs globally, and providing proprietary OTT streaming technology platforms. Cineverse's Matchpoint™ platform supports AVOD, SVOD, TVOD, and linear streaming capabilities, while its IndiCue platform offers location-based CTV advertising solutions. The company holds rights to over 66,000 titles and reaches over 130 million streaming viewers with more than 1.5 million SVOD subscribers. Cineverse partners with major digital platforms and device manufacturers to expand its reach and monetization capabilities. The company also pursues mergers and acquisitions to enhance its technology and content offerings, aiming to grow its audience and revenue streams through advertising, subscriptions, merchandising, and services.
Binah Capital Group, Inc. is a consolidator of retail wealth management businesses owning and operating ten entities, including broker-dealers, registered investment advisors, and insurance entities. The company supports over 1,600 registered individuals in the financial services industry. It offers three operating models—hybrid, independent, and W2—allowing affiliated advisors to choose the model that best suits their practice. The platform provides a variety of custody and clearing firm options to accommodate advisors' unique business needs. Revenue is primarily derived from fees and commissions on products and advisory services offered by advisors to their clients, with a substantial portion paid out to advisors. As of June 30, 2026, total advisory and brokerage assets served were $31.6 billion, with advisory assets at $3.3 billion and brokerage assets at $28.3 billion. The company reported total revenue of approximately $46.5 million and net income of $0.3 million for the quarter ended June 30, 2026. The company is sensitive to macroeconomic factors and U.S. financial markets, including interest rate policies by the Federal Reserve [S2][N1][N2][N4].
Gemini Space Station, Inc. is a cryptocurrency platform founded in 2014 with a mission to build secure financial infrastructure for digital assets and markets. The company offers a unified platform integrating spot and derivatives trading, staking, OTC trading, institutional custody, a regulated stablecoin, a credit card with crypto rewards, and a CFTC-regulated prediction markets platform. Gemini serves retail and institutional users across more than 60 countries, focusing primarily on the US after exiting certain international markets in 2026. The platform emphasizes security, regulatory compliance, and user experience, holding multiple licenses and certifications. Revenue is generated mainly from transaction fees, custody and staking services, and other crypto-linked products. The company also pursues growth through product innovation, user acquisition, and strategic investments via its venture arm.
Fifth Era Acquisition Corp I is a Cayman Islands exempted blank check company incorporated in May 2024. Its business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, or similar business combination with one or more businesses, focusing on technology-enabled companies in sectors such as internet, enterprise technology, software including AI, fintech, and blockchain. The company completed its IPO in March 2025, raising $230 million, with proceeds held in a Trust Account. It has not yet selected a business combination target or generated any operating revenue. The company has a deadline of March 3, 2027, to complete a business combination or else will liquidate and redeem public shares. The management team has extensive experience and networks in technology and venture capital to source potential targets. The company’s financials as of June 30, 2026, show limited cash and low liquidity ratios, reflecting its status as a shell company.
Karbon Capital Partners Corp. is a company with publicly available SEC filings through 2026, including a recent quarterly report disclosing financial snapshot data. The company maintains a current ratio of 1.58 as of June 30, 2026, reflecting its ability to cover short-term liabilities with current assets. No material litigation or arbitration is reported, and risk factors remain consistent with prior disclosures.
Applied Energetics, Inc. develops advanced directed energy and laser technologies, primarily serving U.S. government agencies such as the Department of the Army. The company’s business model relies heavily on government contracts and grants, which are subject to budgetary and policy uncertainties. Recent years have seen limited revenue generation and significant net losses. The company invests in research and development to advance its technology portfolio but faces challenges in commercializing products. Financial statements indicate ongoing operating losses and a need for additional financing to sustain operations and regulatory compliance. The company holds patents and trade secrets but faces risks related to intellectual property enforcement and regulatory safety standards.
Forbright, Inc. is a financial services company primarily serving middle-market businesses through lending and related banking services. The company competes with a broad range of traditional and non-bank financial institutions, including fintech firms. Its business model relies on loan origination, underwriting, and servicing, with a focus on maintaining strong customer relationships and expanding product offerings. The company pursues organic growth through increased loan production, market penetration, and product development, while also engaging in strategic initiatives such as technology investments and fintech partnerships. Forbright is subject to extensive regulatory oversight and faces operational risks including fraud, technology failures, and third-party service provider dependencies.
Ares Acquisition Corp III is a special purpose acquisition company (SPAC) with no publicly disclosed operating business, revenue, or earnings. The company primarily holds cash and other current assets but reported a net loss in its latest quarterly SEC filing. There is no available information on its sector, industry, or geographic focus.
Cantor Fitzgerald Income Trust, Inc. is a Maryland-based REIT that invests primarily in income-producing commercial real estate and multifamily properties across the United States. The company operates through an externally managed structure, with its advisor responsible for investment sourcing, financing, asset management, and property operations. The portfolio includes a mix of retail, office, industrial, and multifamily residential properties, with ownership interests ranging from controlling stakes to minority positions in Delaware Statutory Trusts. The company conducts continuous public offerings of common stock and preferred stock to raise capital for acquisitions and operations. It reported revenue and net income for Q2 2026 and maintains a NAV per share around $20.37 as of June 30, 2026 [S2].
Marblegate Capital Corp is a company focused on taxi medallion-backed loans and taxi fleet operations, primarily in New York City. Its assets include loans held for investment collateralized by taxi medallions, taxi vehicles, and indefinite-lived intangible assets representing taxi medallions. The company uses fair value accounting for its loan portfolio, which involves significant judgment and unobservable inputs. Marblegate operates one of the largest taxi fleets in New York City and supports drivers through taxi clubhouses. The company finances its operations through credit facilities and term loans, with a focus on scaling fleet operations and managing loan portfolios. Financial statements are prepared under U.S. GAAP and audited by Deloitte & Touche LLP. The company is classified as an emerging growth company under the JOBS Act, allowing extended transition periods for new accounting standards.
Collective Acquisition Corp. II operates as a special purpose acquisition company (SPAC) with the primary objective of identifying and completing a business combination with one or more operating businesses. The company holds capital raised from its initial public offering in trust until a suitable acquisition target is identified and approved by shareholders. The business model centers on leveraging the SPAC structure to facilitate mergers or acquisitions, typically within a defined timeframe.